Splice-site mutations in the melanocortin-2 receptor accessory protein that lead to early-onset familial glucocorticoid deficiency type 2

2019 ◽  
Author(s):  
Younus Qamar ◽  
Avinaash Maharaj ◽  
Li Chan ◽  
Asma Deeb ◽  
Louise Metherell
Keyword(s):  
Splice Site ◽  
Early Onset ◽  
Accessory Protein ◽  
Glucocorticoid Deficiency ◽  
Deficiency Type ◽  
Receptor Accessory Protein

scholarly journals Missense Mutations in the Melanocortin 2 Receptor Accessory Protein That Lead to Late Onset Familial Glucocorticoid Deficiency Type 2

Endocrinology ◽  
2010 ◽  
Vol 151 (6) ◽  
pp. 2957-2958
Author(s):  
C. R. Hughes ◽  
T. T. Chung ◽  
A. M. Habeb ◽  
F. Kelestimur ◽  
A. J. L. Clark ◽  
...  
Keyword(s):  
Late Onset ◽  
Accessory Protein ◽  
Missense Mutations ◽  
Glucocorticoid Deficiency ◽  
Deficiency Type ◽  
Receptor Accessory Protein

scholarly journals Clinical and biological phenotype of a patient with familial glucocorticoid deficiency type 2 caused by a mutation of melanocortin 2 receptor accessory protein

2007 ◽  
Vol 157 (4) ◽  
pp. 539-542 ◽  
Author(s):  
H Rumié ◽  
L A Metherell ◽  
A J L Clark ◽  
V Beauloye ◽  
M Maes
Keyword(s):  
Case History ◽  
Accessory Protein ◽  
Acth Receptor ◽  
Biological Phenotype ◽  
History Of ◽  
Glucocorticoid Deficiency ◽  
Deficiency Type ◽  
Receptor Accessory Protein

Familial glucocorticoid deficiency (FGD) is a rare inherited disorder which may be caused by mutations in the ACTH receptor (melanocortin 2 receptor, MC2R) named FGD type 1 or by mutations in the MC2R accessory protein (MRAP) named FGD type 2. We report the case history of a male patient from birth until adulthood with FGD type 2, confirmed by a mutation of the MRAP gene.

Linkage of one gene for familial glucocorticoid deficiency type 2 (FGD2) to chromosome 8q and further evidence of heterogeneity

2002 ◽  
Vol 111 (4-5) ◽  
pp. 428-434 ◽  
Author(s):  
Emmanuelle Génin ◽  
Angela Huebner ◽  
Christine Jaillard ◽  
Armelle Faure ◽  
Georges Halaby ◽  
...  
Keyword(s):  
Glucocorticoid Deficiency ◽  
Deficiency Type

Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2

2005 ◽  
Vol 37 (2) ◽  
pp. 166-170 ◽  
Author(s):  
Louise A Metherell ◽  
J Paul Chapple ◽  
Sadani Cooray ◽  
Alessia David ◽  
Christian Becker ◽  
...  
Keyword(s):  
Acth Receptor ◽  
Glucocorticoid Deficiency ◽  
Deficiency Type

Mutations in a Novel Gene, Encoding a Single Transmembrane Domain Protein Are Associated with Familial Glucocorticoid Deficiency Type 2

2004 ◽  
Vol 30 (4) ◽  
pp. 889-890 ◽  
Author(s):  
Louise A. Metherell ◽  
Sadani Cooray ◽  
Angela Huebner ◽  
Franz Ruschendorf ◽  
Danielle Naville ◽  
...  
Keyword(s):  
Transmembrane Domain ◽  
Gene Encoding ◽  
Novel Gene ◽  
Domain Protein ◽  
Glucocorticoid Deficiency ◽  
Deficiency Type

scholarly journals Familial Glucocorticoid Deficiency Type 2 in Two Neonates

2003 ◽  
Vol 23 (1) ◽  
pp. 62-66 ◽  
Author(s):  
Pallath Ramachandran ◽  
Armelle Penhoat ◽  
Danielle Naville ◽  
Martine Begeot ◽  
Laila Osama Abdel-Wareth ◽  
...  
Keyword(s):  
Glucocorticoid Deficiency ◽  
Deficiency Type

scholarly journals In Vitro Splicing Assay Proves the Pathogenicity of Intronic Variants in MRAP

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A85-A86
Author(s):  
Chris Smith ◽  
Avinaash Vickram Maharaj ◽  
Younus Qamar ◽  
Jordan Read ◽  
Jack Williams ◽  
...  
Keyword(s):  
Splice Site ◽  
Early Onset ◽  
Neonatal Period ◽  
Donor Splice Site ◽  
Homozygous Mutation ◽  
Start Site ◽  
Donor Splice ◽  
In Vitro Splicing ◽  
Glucocorticoid Deficiency

Abstract Introduction: Familial glucocorticoid deficiency (FGD) is characterised by isolated glucocorticoid deficiency in a patient who retains normal mineralocorticoid production. FGD causing mutations in the MC2R accessory protein, MRAP, are often splice-site or nonsense mutations resulting in a truncated protein. Many of these mutations occur at the canonical donor splice-site of intron 3, where it has been shown previously that c.106 + 2_3dupTA, for example, results in skipping of the first coding exon with unknown consequences at the protein level. Patients and methods: DNA was isolated from three consanguineous individuals diagnosed with early onset FGD (0 - 13 months) with high ACTH and/or low cortisol levels and underwent whole exome sequencing. The proband in family 1 (P1) presented at 13 months and had a hyperpigmented sibling who died in neonatal period due to adrenal failure. Patient 2 (P2), who also had a family history of adrenal insufficiency, was noted to be hyperpigmented at birth with markedly raised ACTH, patient 3 (P3) was noted to have diffuse hyperpigmentation in the early neonatal period and on formal testing at 16m was found to have low serum cortisol. Variants were confirmed using Sanger sequencing and predicted splice-site mutations were investigated using an in vitro splicing assay. Results: Homozygous mutations in MRAP were identified in all three cases which were heterozygous in their parents. Previously described mutations, c.106 + 1delG (chr21:33671388delG; rs1476574441; CD050155) in P1 and c.106 + 2dupT (Chr21: 33671390_91insT; rs761576317; CI118288) in P2 at the canonical donor splice-site of intron 3, were identified, with the former predicted to destroy the splice site and the latter to weaken it. These mutations in vitro resulted in the complete skipping of exon 3, which contains the translational start site, and presumably result in no protein product. A novel homozygous mutation in intron 4, c.206 + 5G>T; (chr21:33679055G>T rs1064796398) was identified in P3, but was not predicted to alter splicing. In vitro, this mutation negates the canonical donor splice site and creates two different alternative sites, both resulting in frameshifts and predicted early termination of the protein (p.Val44fs*50, p.Pro72fs*90). Conclusion: All mutations reported here are predicted to produce no protein, either because the start site is excluded (for c.106 + 1delG and c.106 + 2dupT) or because the transcripts are likely to undergo nonsense mediated decay (for c.206 + 5G>T), resulting in the early onset FGD seen in the patients. Splice prediction protocols, although effective for variants within 2bp of exon/intron boundaries may not predict the true outcome of a base change whereas the splice assay conclusively revealed the effect of all three variants allowing us to assign pathogenicity to them.

scholarly journals Familial Glucocorticoid Deficiency Type 2: A Case Report - Case Report

2010 ◽  
Vol 2 (3) ◽  
pp. 122-125 ◽  
Author(s):  
Leyla Akın ◽  
Selim Kurtoğlu ◽  
Mustafa Kendirci ◽  
Mustafa Ali Akın
Keyword(s):  
Case Report ◽  
Glucocorticoid Deficiency ◽  
Deficiency Type
Sign in / Sign up

Export Citation Format

Share Document